Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects, interactions and indications.
Related/similar drugs Aricept Aricept is used to treat mild to severe dementia caused by Alzheimer's disease. Learn about side ... Reviews & ratings 5.3 / 10 40 Reviews View more Namenda Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects ... ...
Memantine (Ebixa®, Axura®, Namenda®, Akatinol®) is a moderate-affinity, uncompetitive, voltage-dependent, NMDA-receptor antagonist with fast on/off kinetics that inhibits excessive calcium influx induced by chronic overstimulation of the NMDA receptor. Memantine is approved in the US and ...
Memantine (Ebixa, Axura, Namenda, Akatinol) (Fig. 2) is a low–moderate affinity NMDA receptor antagonist often prescribed for AD patients who do not tolerate AChEI drugs such as donepezil [349]. Memantine, in combination with donepezil, is approved as a treatment for AD in many countries ...
Beneficiaries were continuously enrolled in a Medicare Advantage plan from 2004 to 2007. Outcome variables were any use of donepezil (Aricept®), galantamine (Razadyne®), rivastigmine (Exelon®), tacrine (Cognex®), or memantine (Namenda®) each year and the number of 30-day ...
refers to a phantom auditory sensation for which no Drug therapy for tinnitus: pharmacological studies . . . . . . . . . . . 383 objective sound can be identified. Summary and outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....
Memantine (brand name Namenda) is an oral NMDA blocker that may be used to treat moderate to severe dementia in people with Alzheimer’s disease.
Related/similar drugsNamenda Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects ...Reviews & ratings 5.8 / 10 33 Reviews View more Exelon Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ... Reviews & ...
in which bupropion synergistically increases dextromethorphan exposure. This consistent pharmacokinetic profile may not be achieved with individual dextromethorphan and bupropion treatments of similar dosages, especially if bupropion concentration was too low to adequately inhibit cytochrome P450 2D6. As such,...
Memantine is generally well tolerated, with adverse events occurring with a similar incidence to that reported with placebo. In modelled cost-effectiveness analyses, memantine was dominant to no therapy in regard to cost per quality-adjusted life-year (QALY) gained, and the combination of memantine...